Evolent Health, Inc. EVH · Stock Open Evolent Health, Inc. in new tab
Evolent Health, Inc. Analysis (EVH)
Is Evolent Health, Inc. a good investment? Evolent Health, Inc. (EVH) is currently trading at 3.14 USD. Market analysts have a consensus price target of 5.83 USD. This suggests a potential upside from current levels.
Earnings Schedule: Evolent Health, Inc. is expected to release its next earnings report on Aug. 6, 2026. The market consensus estimate for Forward EPS is 0.36.
Investor FAQ
Does Evolent Health, Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is Evolent Health, Inc.?
Evolent Health, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Aug. 6, 2026. The company currently has a trailing EPS of -4.68.
Company Profile
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides Machinify Auth Intelligence, an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
Community Discussion